: Investigating the evaluation of eligibility for transplant in myelofibrosis (MF): The role of HCT-CI and BMI. HCT-CI emerges as a key prognostic factor, while BMI shows limited impact. This study expands insights for better clinical decision-making in MF allo-HCT.
Impact of comorbidities and body mass index on the outcomes of allogeneic hematopoietic cell transplantation in myelofibrosis: A study on behalf of the Chronic Malignancies Working Party of EBMT / Polverelli, N., Bonneville, E.F., de Wreede, L.C., Koster, L., Kroger, N.M., Schroeder, T., Peffault de Latour, R., Passweg, J., Sockel, K., Broers, A.E.C., Clark, A., Dreger, P., Blaise, D., Yakoub-Agha, I., Petersen, S.L., Finke, J., Chevallier, P., Helbig, G., Rabitsch, W., Sammassimo, S., et al.. - In: AMERICAN JOURNAL OF HEMATOLOGY. - ISSN 0361-8609. - 99:5(2024), pp. 993-996. [10.1002/ajh.27262]
Impact of comorbidities and body mass index on the outcomes of allogeneic hematopoietic cell transplantation in myelofibrosis: A study on behalf of the Chronic Malignancies Working Party of EBMT
Battipaglia G.;
2024
Abstract
: Investigating the evaluation of eligibility for transplant in myelofibrosis (MF): The role of HCT-CI and BMI. HCT-CI emerges as a key prognostic factor, while BMI shows limited impact. This study expands insights for better clinical decision-making in MF allo-HCT.| File | Dimensione | Formato | |
|---|---|---|---|
|
2024 - Polverelli - Impact of comorbidities and body mass index on the outcomes of allogeneic - American J Hematol.pdf
non disponibili
Tipologia:
Versione Editoriale (PDF)
Licenza:
Non specificato
Dimensione
1.1 MB
Formato
Adobe PDF
|
1.1 MB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
